BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 17884168)

  • 1. Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture.
    Shields JA; Shields CL; Mashayekhi A; Marr BP; Benavides R; Thangappan A; Phan L; Eagle RC
    Ophthalmology; 2008 Mar; 115(3):511-519.e2. PubMed ID: 17884168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary acquired melanosis of the conjunctiva: experience with 311 eyes.
    Shields JA; Shields CL; Mashayekhi A; Marr BP; Benavides R; Thangappan A; Phan L; Eagle RC
    Trans Am Ophthalmol Soc; 2007; 105():61-71; discussion 71-2. PubMed ID: 18427595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary acquired melanosis of the conjunctiva.
    Folberg R; McLean IW; Zimmerman LE
    Hum Pathol; 1985 Feb; 16(2):129-35. PubMed ID: 3972395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary acquired melanosis with atypia treated with mitomycin C.
    Anandajeya WV; Corrêa ZM; Augsburger JJ
    Int Ophthalmol; 2009 Aug; 29(4):285-8. PubMed ID: 18438612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Conjunctival primary acquired melanosis].
    Krohn J; Monge OR
    Tidsskr Nor Laegeforen; 2005 Sep; 125(18):2480-2. PubMed ID: 16186865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary acquired melanosis of the conjunctiva.
    Lin SM; Ferrucci S
    Optometry; 2006 May; 77(5):223-8. PubMed ID: 16651212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
    Demirci H; McCormick SA; Finger PT
    Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a short-term topical interferon α-2b treatment for histologically proven melanoma and primary acquired melanosis with atypia.
    Garip A; Schaumberger MM; Wolf A; Herold TR; Miller CV; Klingenstein A; Schebitz-Walter K; Hintschich CR
    Orbit; 2016; 35(1):29-34. PubMed ID: 26636727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of a primary acquired melanosis of the conjunctiva with atypia by low dose of Mitomycin C 0.02 % - case report with follow up of 2 years].
    Schmidt M; Maier M; Schmidt T; Klaehsen D; Merté RL
    Klin Monbl Augenheilkd; 2001 Dec; 218(12):805-9. PubMed ID: 11805873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjunctival melanosis and melanoma.
    Folberg R; McLean IW; Zimmerman LE
    Ophthalmology; 1984 Jun; 91(6):673-8. PubMed ID: 6462625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary acquired melanosis/melanoma: utility of conjunctival map biopsy.
    Soto H; Bowen RC; Raval V; Yeaney G; Singh A
    Br J Ophthalmol; 2022 May; 106(5):605-609. PubMed ID: 33355161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential immunoreactivity of melanocytic lesions of the conjunctiva.
    Sharara NA; Alexander RA; Luthert PJ; Hungerford JL; Cree IA
    Histopathology; 2001 Oct; 39(4):426-31. PubMed ID: 11683945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary acquired melanosis and melanoma of the conjunctiva.
    Vereecken G; Gobert A; De Laey JJ; Hanssens M
    Bull Soc Belge Ophtalmol; 1996; 263():97-100. PubMed ID: 9396194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops].
    Groh MJ; Holbach LM; Kühnel B; Conway RM; Naumann GO
    Ophthalmologe; 2003 Sep; 100(9):708-12. PubMed ID: 14504895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
    Shields CL
    Trans Am Ophthalmol Soc; 2000; 98():471-92. PubMed ID: 11190037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant melanoma on primary acquired conjunctival melanosis].
    Meyer A; D'Hermies F; Schwartz L; Morel X; Elmaleh C; Renard G
    J Fr Ophtalmol; 1999 Nov; 22(9):983-6. PubMed ID: 10609177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience.
    Kurli M; Finger PT
    Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1108-14. PubMed ID: 15940485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjunctival melanoma arising from primary acquired melanosis in a patient with neurofibromatosis type I.
    Stacy RC; Kenyon KR; Jakobiec FA; Colby KA
    Cornea; 2010 Feb; 29(2):232-4. PubMed ID: 20023582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant melanoma of the conjunctiva.
    Folberg R; McLean IW; Zimmerman LE
    Hum Pathol; 1985 Feb; 16(2):136-43. PubMed ID: 3972396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-risk and high-risk histologic features in conjunctival primary acquired melanosis with atypia: Clinicopathologic analysis of 29 cases.
    Sugiura M; Colby KA; Mihm MC; Zembowicz A
    Am J Surg Pathol; 2007 Feb; 31(2):185-92. PubMed ID: 17255762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.